Suppression of native defense mechanisms, SIRT1 and PPARγ, by dietary glycoxidants precedes disease in adult humans; Relevance to lifestyle-engendered chronic diseases

Amino Acids

Volumn 46, Issue 2, 2014, Pages 301-309

  Uribarri, Jaime ^a   Cai, Weijing ^a   Pyzik, Renata ^a   Goodman, Susan ^a   Chen, Xue ^a   Zhu, Li ^a   Ramdas, Maya ^a   Striker, Gary E ^a   Vlassara, Helen ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Glycation; Host defense mechanisms; Insulin resistance; Nutrition; Oxidative stress

Indexed keywords

AGED; BIOLOGICAL MARKERS; CELL LINE; CHRONIC DISEASE; COOKING; FEMALE; FOOD HABITS; GENE EXPRESSION; GENE SILENCING; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LIFE STYLE; LYSINE; MALE; MIDDLE AGED; OXIDATIVE STRESS; PPAR GAMMA; SIRTUIN 1;

EID: 84895908651     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-013-1502-4     Document Type: Conference Paper

References (29)

1. Beeri MS, Moshier E, Schmeidler J, Gobold J, Uribarri J, Reddy S, Sano M, Grossman HT, Cai W, Vlassara H, Silverman JM (2011) Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals. Mech Ageing Dev 132:583-587
2. Blanquicett C, Kang BY, Ritzenthaler JD, Jones DP, Hart CM (2010) Oxidative stress modulates PPARγ in vascular endothelial cells. Free Radic Biol Med 48:1618-1625
3. Cai W, Gao QD, Zhu L, Peppa M, He C, Vlassara H (2002) Oxidative stress-induced carbonyl compounds from common foods: novel mediators of cellular dysfunction. Mol Med 8:337-346
4. Cai W, He JC, Zhu L, Chen X, Zheng F, Striker GE, Vlassara H (2008) Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan. Am J Pathol 173(2):327-336
5. Cai W, Ramdas M, Zhu L, Chen X, Striker GE, Vlassara H (2012) Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1. Proc Natl Acad Sci USA 109:15888-15893
6. Cardellini M, Menghini R, Martelli E, Casagrande V, Marino A, Rizza S, Porzio O, Mauriello A, Solini A, Ippoliti A, Lauro R, Folli F, Federici M (2009) TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SIRT1. Diabetes 58:2396-2401
7. Chawla A, Barrak Y, Nagy L, Liao D, Tontonoz P, Evans RM (2001) PPR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat Med 7:48-52
8. Chinetti G, Lestavel S, Bocher V, Remaley AT, Never B, Torra IP, Treiussier E, Minnich A, Jaye M, Duverger N, Brewer HB, Fruchart JC, Clavey V, Staels B (2001) PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med 7:53-58
9. Dandona P, Alijada A, Chaudhuri A, Morahanty P, Grag R (2005) Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes and inflammation. Circulation 111:1448-1454
10. De Kreutzenberg SV, Ceolotto G, Papparella I, Bortoluzzi A, Semplicini A, Dalla Man C, Cobelli C, Fadini GP, Avogaro A (2010) Downregulation of the longevity-associated protein SIRT1 in insulin resistance and metabolic syndrome. Potential biochemical mechanisms. Diabetes 59:1006-1015
11. El Midaoui A, Wu L, Wang R, de Champlain J (2006) Modulation of cardiac and aortic peroxisome proliferator-activated receptor-gamma expression by oxidative stress in chronically glucose-fed rats. Am J Hypertens 19:407-412
12. Guarente L (2011) Sirtuins, aging and medicine. New Eng J Med 364:2235-2243
13. Han L, Zhou R, Niu J, McNutt MA, Wang P, Tong T (2010) SIRT1 is regulated by a PPARγ-SIRT1 negative feedback loop associated with senescence. Nucleic Acids Res 38:7458-7468
14. Hevener AL, Olefsky JM, Reichart D, Nguyen MTA, Bandyopadyhay G, Leung HY, Watt MJ, Bebber C, Febbraio MA, Nguyen AK, Folian B, Subramaniam S, Gonzalez FJ, Glass C, Ricote M (2007) Macrophage PPARγ is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thaizolidinediones. J Clin Invest 117:1658-1669
15. Hofmann S, Dong HJ, Cai W, Altomonte J, Thung SN, Zeng F, Fisher EA, Vlassara H (2002) Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. Diabetes 51:2082-2089
16. Kersten S, Desverfgne B, Wahil W (2000) Roles of PPARs in health and disease. Nature 405:421-424
17. Koschinsky T, He JC, Liu C, Buenting C, Heitmann K, Vlassara H (1997) Orally absorbed reactive advanced glycation end products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci 94:6474-6479
18. Liang F, Kume S, Koya D (2009) SIRT1 and insulin resistance. Nat Rev Endocrinol 5:367-373
19. Libby P (2003) Inflammation in atherosclerosis. Nature 420:868-874
20. Lin RY, Reis ED, Dore AT, Lu M, Ghodsi N, Fallon JT, Fisher EA, Vlassara H (2002) Lowering of dietary advanced glycation endproducts (AGE) reduces neointimal formation after arterial injury in genetically hypercholesterolemic mice. Atherosclerosis 163:303-311
21. Olefsky JM, Glass CK (2010) Macrophages, inflammation and insulin resistance. Ann Rev Physiol 72:219-246
22. Peppa M, He C, Hattori M, McEvoy R, Zheng F, Vlassara H (2003) Fetal or neonatal low-glycotoxin environment prevents autoimmune diabetes in NOD mice. Diabetes 52:1441-1448
23. Uribarri J, Peppa M, Cai W, Goldberg T, Lu M, He C, Vlassara H (2003a) Restriction of dietary glycotoxin reduces excessive advanced glycation end products in renal failure patients. J Am Soc Nephrol 14(3):728-731
24. Uribarri J, Peppa M, Cai W, Goldberg T, Lu M, Baliga S, Vassalotti JA, Vlassara H (2003b) Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients. Am J Kid Dis 43:532-538
25. Uribarri J, Woodruff S, Goodman S, Cai W, Chen X, Pyzik R, Yong A, Striker GE, Vlassara H (2010) Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc 110:911-916
26. Uribarri J, Cai W, Ramdas M, Goodman S, Pyzick R, Chen X, Zhu L, Striker GE, Vlassara H (2011) Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1. Diabetes Care 34:1610-1616
27. Vlassara H, Cai W, Crandall J, Goldberg T, Oberstein R, Dardaine V, Peppa M, Rayfield EJ (2002) Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci 99:15596-15601
28. Vlassara H, Cai W, Goodman S, Pyzik R, Young A, Chen X, Zhu L, Neade T, Beeri M, Silverman JM, Ferrucci L, Tansman L, Striker GE, Uribarri J (2009) Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGEreceptor-1. J Clin Endocrinol Metab 94:4483-4491
29. Zheng F, He C, Cai W, Hattori M, Steffes M, Vlassara H (2002) Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products. Diab Metab Res Rev 18:224-237